Lee June 4
4 · Tenaya Therapeutics, Inc. · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
Tenaya (TNYA) Director Lee June Receives 120,000-Option Award
What Happened
- Lee June, a director of Tenaya Therapeutics (TNYA), was granted 120,000 stock options on May 28, 2026. The transaction is reported as a derivative award (transaction code A) with an acquisition price shown as $0.00 — i.e., an option grant rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-28; Filing date: 2026-05-29 (timely).
- Reported acquisition: 120,000 shares (derivative option) at $0.00.
- Shares owned after transaction: Not disclosed in the filing.
- Footnote: Option granted under the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests in full on May 28, 2027, or earlier the day immediately before the next annual meeting after the grant, subject to continued service.
- Filing appears timely (no late-report flag).
Context
- This is an equity compensation grant (option award) intended as compensation/retention; options vest over roughly one year per the footnote. Because these are unvested options, they do not represent immediate stock purchases or sales and typically do not indicate near-term insider buying or selling.
Insider Transaction Report
Form 4
Lee June
Director
Transactions
- Award
Stock Option (Right to buy)
[F1]2026-05-28+120,000→ 120,000 totalExercise: $0.80From: 2027-05-28Exp: 2036-05-27→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact|2026-05-29